Frontlight ResearchEarly access
CompletedNo phase
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- Kansas City and St Louis, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 416 people enrolled
- Started
- 21 May 2021
- Ended
- 30 Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- EleVATE Group Care
- Individual Prenatal Care
- Record updated
- 16 October 2026
Who can take part
- Age
- 13 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- English or Spanish speaking
- ≤18 weeks' gestation
- Established prenatal care at EleVATE site
- High-risk for postpartum depression by ≥1 risk factor (personal/family history, baseline EPDS≥10, low-income, 13-19 years old, single, history of physical/sexual abuse, unplanned/undesired pregnancy, history of pregnancy loss)
- Ability to attend group prenatal visits at specified days/times
- Willingness to be randomized
- Ability to give informed consent
- Any patient that has received prenatal care in a group setting previously
Who cannot take part
- Serious medical co-morbidity/psychiatric illness necessitating more care than can be safely provided in group setting
- Multiple gestation
- Major fetal anomaly
- Serious medical co-morbidity necessitating more care than can be safely provided in group setting
Where in United States
- University of Missouri-Kansas City/Truman Health Centers-Kansas CityKansas City, United States
- Affinia HealthcareSt Louis, United States
- CareSTL HealthSt Louis, United States
- Family Care Health CentersSt Louis, United States
About the trial
What the trial wants to find out
This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study indicate that EleVATE GC is feasible and effective, this model could be implemented nationwide to help achieve mental and obstetric health parity for low-income women of color in the United States.
The 2 groups in the trial
- Group Prenatal CareTreatment being tested
Group prenatal care model
Treatment: EleVATE Group Care
- Individual Prenatal CareExisting treatment, for comparison
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 16 October 2026